SANTA FE, N.M.--(BUSINESS WIRE)--July 27, 2006--CytoDyn, Inc. (OTCBB:CYDY - News) has briefed its shareholders on flu vaccines that compete with the DNA plasmids being developed by the company’s wholly owned subsidiary Advanced Influenza Technologies, Inc. (AITI) under license from the University of Massachusetts Medical Center.
